Mount Lucas Management LP Acquires 16,163 Shares of Quanterix Corporation $QTRX

Mount Lucas Management LP increased its holdings in Quanterix Corporation (NASDAQ:QTRX) by 36.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 60,000 shares of the company’s stock after buying an additional 16,163 shares during the period. Mount Lucas Management LP owned 0.13% of Quanterix worth $399,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. William Blair Investment Management LLC boosted its holdings in shares of Quanterix by 2.0% in the second quarter. William Blair Investment Management LLC now owns 1,127,981 shares of the company’s stock worth $7,501,000 after acquiring an additional 21,918 shares during the period. Invenomic Capital Management LP bought a new position in Quanterix in the 1st quarter worth about $5,872,000. Geode Capital Management LLC grew its holdings in Quanterix by 2.4% during the 2nd quarter. Geode Capital Management LLC now owns 887,080 shares of the company’s stock valued at $5,900,000 after buying an additional 21,210 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in Quanterix by 51.1% during the 1st quarter. Russell Investments Group Ltd. now owns 606,787 shares of the company’s stock valued at $3,950,000 after buying an additional 205,311 shares in the last quarter. Finally, Envestnet Asset Management Inc. increased its position in shares of Quanterix by 46.2% during the first quarter. Envestnet Asset Management Inc. now owns 500,398 shares of the company’s stock valued at $3,258,000 after buying an additional 158,134 shares during the period. Institutional investors own 86.48% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on QTRX shares. Weiss Ratings restated a “sell (d-)” rating on shares of Quanterix in a research report on Wednesday, October 8th. Canaccord Genuity Group reissued a “hold” rating and issued a $5.00 price target (down from $12.00) on shares of Quanterix in a report on Monday, August 11th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $10.33.

Quanterix Trading Down 3.7%

Shares of NASDAQ QTRX opened at $5.53 on Tuesday. The business has a 50-day moving average of $5.43 and a 200-day moving average of $5.46. The firm has a market capitalization of $258.31 million, a price-to-earnings ratio of -2.37 and a beta of 1.12. Quanterix Corporation has a 12 month low of $4.05 and a 12 month high of $13.01.

Quanterix (NASDAQ:QTRX) last announced its earnings results on Monday, November 10th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.13). The company had revenue of $40.23 million for the quarter, compared to the consensus estimate of $37.85 million. Quanterix had a negative net margin of 73.47% and a negative return on equity of 21.34%. Quanterix has set its FY 2025 guidance at EPS. On average, analysts predict that Quanterix Corporation will post -0.98 earnings per share for the current year.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.